{"id":6685,"date":"2021-10-04T17:26:23","date_gmt":"2021-10-04T15:26:23","guid":{"rendered":"https:\/\/arterra.pixelleria.com\/?page_id=6685"},"modified":"2026-01-20T12:14:35","modified_gmt":"2026-01-20T11:14:35","slug":"informations-for-shareholders","status":"publish","type":"page","link":"https:\/\/arterrabio.it\/en\/investor-relations\/informations-for-shareholders\/","title":{"rendered":"Informations for shareholders"},"content":{"rendered":"

SOCIAL AND SHARE CAPITAL <\/strong><\/h3>\n

At the start date of the negotiations of ordinary shares and warrants on the Euronext Growth Milan market, the Company\u2019s share capital – fully subscribed and paid up – is equal to Euro 332.924,65, divided into no. 6.658.493 Shares (ISIN IT0005386369), all of which have no nominal value. The minimum trading lot is equal to no. 750 Shares or multiples thereof.<\/p>\n

 <\/p>\n\n\n\n\n\n\n\n\n\n
\n

Sharehoder<\/strong><\/h4>\n<\/td>\n

\n

No. of ordiary shares<\/strong><\/h4>\n<\/td>\n

\n

%<\/strong><\/h4>\n<\/td>\n<\/tr>\n

Maria Gabriella Colucci<\/td>\n1.390.987<\/td>\n20,89%<\/td>\n<\/tr>\n
Alberto Previtali<\/td>\n1.012.500<\/td>\n15,20%<\/td>\n<\/tr>\n
Smart Capital S.p.A.<\/td>\n799.500<\/td>\n12,01%<\/td>\n<\/tr>\n
Intercos S.p.A.<\/td>\n576.000<\/td>\n8,65%<\/td>\n<\/tr>\n
Floating<\/td>\n2.879.506<\/td>\n43,25%<\/td>\n<\/tr>\n
TOTAL<\/strong><\/td>\n6.658.493<\/strong><\/td>\n100,00%<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

EURONEXT GROWTH ADVISOR<\/strong><\/h3>\n

Banca Profilo\u00a0 \u00a0 \"\"<\/p>\n

 <\/p>\n

METHOD OF DISTRIBUTION OF REGULATED INFORMATION <\/b><\/strong><\/h3>\n

For the distribution of Regulated Information, Arterra Bioscience has chosen to make use of the 1Info-SDIR system (www.1info.it), managed by Computershare S.p.A. based in Milan, via Lorenzo Mascheroni 19 and authorized by CONSOB.<\/p>\n

REPORTING OBLIGATIONS OF SIGNIFICANT SHAREHOLDERS<\/b><\/h3>\n

Pursuant to the Euronext Growth Milan (EGM) Issuers’ Regulation approved and published by Borsa Italiana and subsequent amendments and additions (“EGM Issuers\u2019 Regulation”), those who participate in the issuer’s capital must communicate any “Substantial Change” or the achievement or exceeding of the thresholds of 5 %, 10%, 15%, 20%, 25%, 30%, 50%, 66.6% and 90% of the share capital of the EGM issuer, as well as the reduction below the aforementioned thresholds, in order to allow the issuer itself to communicate without delay and make any Substantial Change available to the public. Significant for the calculation of the so-called shareholder\u2019s holdings – i.e. if he holds at least 5% of the share capital – i) the holdings belonging to him (even if the voting right belongs to third parties or is attributed to them); ii) holdings for which voting rights are entitled or attributed; iii) the shares held by intermediaries, trustees, subsidiaries or for which the voting rights are due or attributed to such persons; and iv) the total number of shares transferred in a shareholders\u2019 agreement on exercising voting rights in the issuer. Promptly, and in any case within 4 trading days from the transaction giving rise to the obligation (regardless of the execution date) or from the day on which he became aware of the events that result in a change of the issuer’s share capital, the significant shareholder itself must communicate to the issuer:<\/p>\n

(a) his identity;
\n(b) the date on which the issuer was informed;
\n(c) the date on which the material change of holdings took place;
\n(d) the nature and extent of the significant shareholder’s participation in the transaction.
\nThe communication can be made using the appropriate form that can be downloaded via the below link, to be sent by registered letter with return receipt to the Company at the registered office or via PEC to the address: arterra@pec.it<\/strong><\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

SOCIAL AND SHARE CAPITAL At the start date of the negotiations of ordinary shares and warrants on the Euronext Growth Milan market, the Company\u2019s share capital – fully subscribed and paid up – is equal to Euro 332.924,65, divided into no. 6.658.493 Shares (ISIN IT0005386369), all of which have no nominal value. The minimum trading […]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":6643,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-6685","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nInformations for shareholders - Arterra Bioscience<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/arterrabio.it\/en\/investor-relations\/informations-for-shareholders\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Informations for shareholders - Arterra Bioscience\" \/>\n<meta property=\"og:description\" content=\"SOCIAL AND SHARE CAPITAL At the start date of the negotiations of ordinary shares and warrants on the Euronext Growth Milan market, the Company\u2019s share capital – fully subscribed and paid up – is equal to Euro 332.924,65, divided into no. 6.658.493 Shares (ISIN IT0005386369), all of which have no nominal value. The minimum trading […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/arterrabio.it\/en\/investor-relations\/informations-for-shareholders\/\" \/>\n<meta property=\"og:site_name\" content=\"Arterra Bioscience\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-20T11:14:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/arterrabio.it\/wp-content\/uploads\/2019\/10\/Logo-Banca-Profilo.png\" \/>\n\t<meta property=\"og:image:width\" content=\"547\" \/>\n\t<meta property=\"og:image:height\" content=\"82\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/arterrabio.it\\\/en\\\/investor-relations\\\/informations-for-shareholders\\\/\",\"url\":\"https:\\\/\\\/arterrabio.it\\\/en\\\/investor-relations\\\/informations-for-shareholders\\\/\",\"name\":\"Informations for shareholders - Arterra Bioscience\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/arterrabio.it\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/arterrabio.it\\\/en\\\/investor-relations\\\/informations-for-shareholders\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/arterrabio.it\\\/en\\\/investor-relations\\\/informations-for-shareholders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/arterrabio.it\\\/wp-content\\\/uploads\\\/2019\\\/10\\\/Logo-Banca-Profilo-300x45.png\",\"datePublished\":\"2021-10-04T15:26:23+00:00\",\"dateModified\":\"2026-01-20T11:14:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/arterrabio.it\\\/en\\\/investor-relations\\\/informations-for-shareholders\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/arterrabio.it\\\/en\\\/investor-relations\\\/informations-for-shareholders\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/arterrabio.it\\\/en\\\/investor-relations\\\/informations-for-shareholders\\\/#primaryimage\",\"url\":\"https:\\\/\\\/arterrabio.it\\\/wp-content\\\/uploads\\\/2019\\\/10\\\/Logo-Banca-Profilo-300x45.png\",\"contentUrl\":\"https:\\\/\\\/arterrabio.it\\\/wp-content\\\/uploads\\\/2019\\\/10\\\/Logo-Banca-Profilo-300x45.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/arterrabio.it\\\/en\\\/investor-relations\\\/informations-for-shareholders\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/arterrabio.it\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investor relations\",\"item\":\"https:\\\/\\\/arterrabio.it\\\/en\\\/investor-relations\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Informations for shareholders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/arterrabio.it\\\/#website\",\"url\":\"https:\\\/\\\/arterrabio.it\\\/\",\"name\":\"Arterra Bioscience\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/arterrabio.it\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Informations for shareholders - Arterra Bioscience","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/arterrabio.it\/en\/investor-relations\/informations-for-shareholders\/","og_locale":"en_US","og_type":"article","og_title":"Informations for shareholders - Arterra Bioscience","og_description":"SOCIAL AND SHARE CAPITAL At the start date of the negotiations of ordinary shares and warrants on the Euronext Growth Milan market, the Company\u2019s share capital – fully subscribed and paid up – is equal to Euro 332.924,65, divided into no. 6.658.493 Shares (ISIN IT0005386369), all of which have no nominal value. The minimum trading […]","og_url":"https:\/\/arterrabio.it\/en\/investor-relations\/informations-for-shareholders\/","og_site_name":"Arterra Bioscience","article_modified_time":"2026-01-20T11:14:35+00:00","og_image":[{"width":547,"height":82,"url":"https:\/\/arterrabio.it\/wp-content\/uploads\/2019\/10\/Logo-Banca-Profilo.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/arterrabio.it\/en\/investor-relations\/informations-for-shareholders\/","url":"https:\/\/arterrabio.it\/en\/investor-relations\/informations-for-shareholders\/","name":"Informations for shareholders - Arterra Bioscience","isPartOf":{"@id":"https:\/\/arterrabio.it\/#website"},"primaryImageOfPage":{"@id":"https:\/\/arterrabio.it\/en\/investor-relations\/informations-for-shareholders\/#primaryimage"},"image":{"@id":"https:\/\/arterrabio.it\/en\/investor-relations\/informations-for-shareholders\/#primaryimage"},"thumbnailUrl":"https:\/\/arterrabio.it\/wp-content\/uploads\/2019\/10\/Logo-Banca-Profilo-300x45.png","datePublished":"2021-10-04T15:26:23+00:00","dateModified":"2026-01-20T11:14:35+00:00","breadcrumb":{"@id":"https:\/\/arterrabio.it\/en\/investor-relations\/informations-for-shareholders\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/arterrabio.it\/en\/investor-relations\/informations-for-shareholders\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/arterrabio.it\/en\/investor-relations\/informations-for-shareholders\/#primaryimage","url":"https:\/\/arterrabio.it\/wp-content\/uploads\/2019\/10\/Logo-Banca-Profilo-300x45.png","contentUrl":"https:\/\/arterrabio.it\/wp-content\/uploads\/2019\/10\/Logo-Banca-Profilo-300x45.png"},{"@type":"BreadcrumbList","@id":"https:\/\/arterrabio.it\/en\/investor-relations\/informations-for-shareholders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/arterrabio.it\/en\/"},{"@type":"ListItem","position":2,"name":"Investor relations","item":"https:\/\/arterrabio.it\/en\/investor-relations\/"},{"@type":"ListItem","position":3,"name":"Informations for shareholders"}]},{"@type":"WebSite","@id":"https:\/\/arterrabio.it\/#website","url":"https:\/\/arterrabio.it\/","name":"Arterra Bioscience","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/arterrabio.it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/arterrabio.it\/en\/wp-json\/wp\/v2\/pages\/6685","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arterrabio.it\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/arterrabio.it\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/arterrabio.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/arterrabio.it\/en\/wp-json\/wp\/v2\/comments?post=6685"}],"version-history":[{"count":17,"href":"https:\/\/arterrabio.it\/en\/wp-json\/wp\/v2\/pages\/6685\/revisions"}],"predecessor-version":[{"id":12860,"href":"https:\/\/arterrabio.it\/en\/wp-json\/wp\/v2\/pages\/6685\/revisions\/12860"}],"up":[{"embeddable":true,"href":"https:\/\/arterrabio.it\/en\/wp-json\/wp\/v2\/pages\/6643"}],"wp:attachment":[{"href":"https:\/\/arterrabio.it\/en\/wp-json\/wp\/v2\/media?parent=6685"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}